MENU

PALI Palisade Bio Forecast, Technical & Fundamental Analysis

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier... Show more

PALI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
PALI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PALI is expected to report earnings to rise 20.00% to -5 cents per share on November 09

Palisade Bio PALI Stock Earnings Reports
Q3'26
Est.
$-0.06
Q2'26
Est.
$-0.05
Q1'26
Beat
by $0.39
Q4'25
Beat
by $0.23
Q3'25
Beat
by $0.17
The last earnings report on August 10 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 238.70K shares outstanding, the current market capitalization sits at 243.98M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ACTS25.270.22
+0.88%
FIS Tactical Equity ETF (ACTS)
ATMP35.520.23
+0.65%
Barclays ETN+ Select MLP ETN (ATMP)
GDXJ108.520.68
+0.63%
VanEck Junior Gold Miners ETF (GDXJ)
UPAR15.330.03
+0.17%
UPAR Ultra Risk Parity ETF (UPAR)
ORCX15.88-0.52
-3.17%
Defiance Daily Target 2X Long ORCL ETF (ORCX)

PALI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PALI has been closely correlated with RNAC. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if PALI jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PALI
1D Price
Change %
PALI100%
-2.10%
RNAC - PALI
81%
Closely correlated
+0.39%
AGEN - PALI
81%
Closely correlated
-0.31%
NCNA - PALI
81%
Closely correlated
-2.94%
TAOX - PALI
81%
Closely correlated
+4.88%
NRXP - PALI
74%
Closely correlated
+0.38%
More

Groups containing PALI

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PALI
1D Price
Change %
PALI100%
-2.10%
PALI
(5 stocks)
41%
Loosely correlated
+0.10%
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds

Industry Biotechnology

Industry
N/A
Address
4600 South Syracuse Street
Phone
+1 858 704-4900
Employees
14
Web
https://www.palisadebio.com
Palisade Bio (PALI) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com